Original Research Gynecology| Volume 221, ISSUE 2, P126.e1-126.e18, August 2019

Neonatal and maternal outcome after frozen embryo transfer: Increased risks in programmed cycles

Published:March 22, 2019DOI:


      Frozen embryo transfer is associated with better perinatal outcome regarding preterm birth and low birthweight, yet higher risk of large for gestational age and macrosomia compared to fresh transfer. Further, higher rates of hypertensive disorders in pregnancy are noted after frozen embryo transfer. Whether these differences are due to the protocol used in frozen cycles remains unknown.


      To analyze the obstetric outcome after frozen embryo transfer depending on protocol used. Comparison was also made for frozen vs fresh transfer and for frozen transfer vs spontaneous conception.

      Study Design

      A population-based retrospective registry study including all singletons born after frozen embryo transfer in Sweden from 2005 to 2015. The in vitro fertilization register was cross-linked with the Medical Birth Register, the Register of Birth Defects, the National Patient Register, the Swedish Neonatal Quality Register, and the Prescribed Drug Register. Singletons after frozen embryo transfer were compared depending on the presence of a corpus luteum in the actual cycle. All frozen transfer singletons were also compared with fresh transfer and spontaneous conception singletons. Primary outcomes were preterm birth (<37 w), low birthweight (<2500 g), hypertensive disorders in pregnancy, and postpartum hemorrhage (>1000 mL). Crude and adjusted odds ratio with 95% confidence interval were calculated and adjustment made for relevant confounders.


      A total of 9726 singletons were born after frozen embryo transfer (natural cycles, n = 6297; stimulated cycles, n = 1983; programmed cycles, n = 1446), 24,365 after fresh transfer, and 1,127,566 after spontaneous conception. No significant differences were noticed for preterm birth and low birthweight between the different protocols used in frozen embryo transfer. Compared to natural and stimulated frozen cycles, programmed frozen cycles were associated with a higher risk of hypertensive disorders in pregnancy (adjusted odds ratio, 1.78; 95% confidence interval, 1.43–2.21 and adjusted odds ratio, 1.61; 95% confidence interval, 1.22–2,10, respectively) and postpartum hemorrhage (adjusted odds ratio, 2.63; 95% confidence interval, 2.20–3.13 and adjusted odds ratio, 2.87; 95% confidence interval, 2.29–2.60, respectively). Moreover, higher risks for postterm birth (adjusted odds ratio, 1.59; 95% confidence interval, 1.27–2.01 and adjusted odds ratio, 1.98; 95% confidence interval, 1.47–2.68) and macrosomia (adjusted odds ratio, 1.62; 95% confidence interval, 1.26–2.09 and adjusted odds ratio, 1.40; 95% confidence interval, 1.03–1.90) were detected. There were no significant differences in any outcomes between stimulated and natural cycles. Frozen cycles in general compared to fresh cycles and compared to spontaneous conceptions showed neonatal and maternal outcomes in agreement with earlier studies.


      No significant difference could be seen regarding preterm birth and low birthweight between the different protocols. However, higher rates of hypertensive disorders in pregnancy, postpartum hemorrhage, postterm birth, and macrosomia were detected in programmed cycles. Stimulated cycles had outcomes similar to natural cycles. These findings are important in view of the increasing use of frozen cycles and the new policy of freeze-all cycles in in vitro fertilization. The results suggest a link between the absence of corpus luteum and adverse obstetric outcomes.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • De Geyter C.
        • Calhaz-Jorge C.
        • Kupka M.S.
        • et al.
        ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE).
        Hum Reprod. 2018; 33: 1586-1601
      1. Prevention CfDCa. Accessed March 1, 2019

        • Shi Y.
        • Sun Y.
        • Hao C.
        • et al.
        Transfer of fresh versus frozen embryos in ovulatory women.
        N Engl J Med. 2018; 378: 126-136
        • Vuong L.N.
        • Dang V.Q.
        • Ho T.M.
        • et al.
        IVF transfer of fresh or frozen embryos in women without polycystic ovaries.
        N Engl J Med. 2018; 378: 137-147
        • Wong K.M.
        • van Wely M.
        • Mol F.
        • Repping S.
        • Mastenbroek S.
        Fresh versus frozen embryo transfers in assisted reproduction.
        Cochrane Database Syst Rev. 2017; 3: Cd011184
        • Chen Z.J.
        • Legro R.S.
        Fresh versus frozen embryos in polycystic ovary syndrome.
        N Engl J Med. 2016; 375: e42
        • Maheshwari A.
        • Pandey S.
        • Amalraj Raja E.
        • Shetty A.
        • Hamilton M.
        • Bhattacharya S.
        Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?.
        Hum Reprod Update. 2018; 24: 35-58
        • Wennerholm U.B.
        • Henningsen A.K.
        • Romundstad L.B.
        • et al.
        Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group.
        Hum Reprod. 2013; 28: 2545-2553
        • Zhang B.
        • Wei D.
        • Legro R.S.
        • et al.
        Obstetric complications after frozen versus fresh embryo transfer in women with polycystic ovary syndrome: results from a randomized trial.
        Fertil Steril. 2018; 109: 324-329
        • Berntsen S.
        • Pinborg A.
        Large for gestational age and macrosomia in singletons born after frozen/thawed embryo transfer (FET) in assisted reproductive technology (ART).
        Birth Defects Res. 2018; 110: 630-643
        • Sazonova A.
        • Källen K.
        • Thurin-Kjellberg A.
        • Wennerholm U.B.
        • Bergh C.
        Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos.
        Hum Reprod. 2012; 27
        • Opdahl S.
        • Henningsen A.A.
        • Tiitinen A.
        • Bergh C.
        • Pinborg A.
        • Romundstad P.R.
        Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group.
        Hum Reprod. 2015; 30
        • Ghobara T.
        • Gelbaya T.A.
        • Ayeleke R.O.
        Cycle regimens for frozen-thawed embryo transfer.
        Cochrane Database Syst Rev. 2017; 7: Cd003414
        • Groenewoud E.R.
        • Cohlen B.J.
        • Al-Oraiby A.
        • et al.
        A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer.
        Hum Reprod. 2016; 31: 1483-1492
        • von Versen-Hoynck F.
        • Narasimhan P.
        • Selamet Tierney E.S.
        • et al.
        Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy.
        Hypertension. 2019; 73: 680-690
        • von Versen-Hoynck F.
        • Schaub A.M.
        • Chi Y.Y.
        • et al.
        Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum.
        Hypertension. 2019; 73: 640-649
        • von Versen-Hoynck F.
        • Strauch N.K.
        • Liu J.
        • et al.
        Effect of mode of conception on maternal serum relaxin, creatinine, and sodium concentrations in an infertile population.
        Reprod Sci. 2019; 26: 412-419
      2. National Registry of Assisted Reproduction (Q-IVF).
        (Available at:) (Accessed March 1, 2019)
        • Cnattingius S.
        • Ericson A.
        • Gunnarskog J.
        • Kallen B.
        A quality study of a medical birth registry.
        Scand J Soc Med. 1990; 18: 143-148
      3. (Accessed March 1, 2019)
      4. (Accessed March 1, 2019)
      5. Statistics Sweden.
        (Available at) (Accessed March 1, 2019)
        • Marsal K.
        • Persson P.H.
        • Larsen T.
        • Lilja H.
        • Selbing A.
        • Sultan B.
        Intrauterine growth curves based on ultrasonically estimated foetal weights.
        Acta Paediatr. 1996; 85: 843-848
      6. (Accessed March 1, 2019)
        • Roos N.
        • Kieler H.
        • Sahlin L.
        • Ekman-Ordeberg G.
        • Falconer H.
        • Stephansson O.
        Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study.
        BMJ. 2011; 343: d6309
        • Luke B.
        • Gopal D.
        • Cabral H.
        • Stern J.E.
        • Diop H.
        Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.
        Am J Obstet Gynecol. 2017; 217: 327.e1-327.e14
        • Rasmussen S.
        • Irgens L.M.
        Fetal growth and body proportion in preeclampsia.
        Obstet Gynecol. 2003; 101: 575-583
        • Sha T.
        • Yin X.
        • Cheng W.
        • Massey I.Y.
        Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis.
        Fertil Steril. 2018; 109: 330-342.e9
        • Roque M.
        • Valle M.
        • Sampaio M.
        • Geber S.
        Obstetric outcomes after fresh versus frozen-thawed embryo transfers: A systematic review and meta-analysis.
        JBRA Assist Reprod. 2018; 22: 253-260
        • Palomba S.
        • de Wilde M.A.
        • Falbo A.
        • Koster M.P.
        • La Sala G.B.
        • Fauser B.C.
        Pregnancy complications in women with polycystic ovary syndrome.
        Hum Reprod Update. 2015; 21: 575-592
        • Imudia A.N.
        • Awonuga A.O.
        • Doyle J.O.
        • et al.
        Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization.
        Fertil Steril. 2012; 97: 1374-1379
        • Pereira N.
        • Elias R.T.
        • Christos P.J.
        • et al.
        Supraphysiologic estradiol is an independent predictor of low birth weight in full-term singletons born after fresh embryo transfer.
        Hum Reprod. 2017; 32: 1410-1417
        • Luke B.
        • Brown M.B.
        • Wantman E.
        • Stern J.E.
        • Toner J.P.
        • Coddington 3rd, C.C.
        Increased risk of large-for-gestational age birthweight in singleton siblings conceived with in vitro fertilization in frozen versus fresh cycles.
        J Assist Reprod Genet. 2017; 34: 191-200
        • Nejdet S.
        • Bergh C.
        • Kallen K.
        • Wennerholm U.B.
        • Thurin-Kjellberg A.
        High risks of maternal and perinatal complications in singletons born after oocyte donation.
        Acta Obstet Gynecol Scand. 2016; 95: 879-886
        • Storgaard M.
        • Loft A.
        • Bergh C.
        • et al.
        Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis.
        BJOG. 2017; 124: 561-572
        • Gundogan F.
        • Bianchi D.W.
        • Scherjon S.A.
        • Roberts D.J.
        Placental pathology in egg donor pregnancies.
        Fertil Steril. 2010; 93: 397-404
        • Levron Y.
        • Dviri M.
        • Segol I.
        • et al.
        The ‘immunologic theory' of preeclampsia revisited: a lesson from donor oocyte gestations.
        Am J Obstet Gynecol. 2014; 211: 383.e1-383.e5